SVT Overview

TransDigm Acquires Servotronics: TransDigm Group has successfully completed its acquisition of Servotronics, purchasing shares at $47.00 each, with 87.09% of outstanding shares tendered by the deadline on June 30, 2025.

Servotronics Delisting: Following the acquisition, Servotronics' common stock will cease trading on NYSE American, and shareholders who did not tender their shares will receive the same purchase price as part of the merger process.

Star Equity Fund's Influence: Star Equity Fund successfully advocated for Servotronics to explore strategic alternatives, leading to a tender offer from TransDigm at a significant premium, which validated their belief that Servotronics was undervalued.

Shareholder Value Creation: The advocacy efforts resulted in substantial changes within Servotronics' Board and operations, ultimately benefiting all shareholders and stakeholders through the completion of the acquisition by TransDigm.

Star Equity Fund's Influence: Star Equity Fund successfully advocated for Servotronics to explore strategic alternatives, leading to a tender offer from TransDigm at $47.00 per share, representing a 357% premium over the previous closing price.

Shareholder Value Creation: The advocacy efforts resulted in significant changes within Servotronics' Board, including new independent directors and the termination of a poison pill, ultimately validating Star Equity Fund's belief that the company's shares were undervalued.

Investigation of Companies: Halper Sadeh LLC is investigating potential violations of federal securities laws and fiduciary duties related to the sales of Blueprint Medicines Corporation, Servotronics, Inc., and Southern States Bancshares, Inc. to other companies, with specific terms outlined for each transaction.

Legal Rights for Shareholders: Shareholders of the mentioned companies are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options regarding the proposed transactions, with the firm offering services on a contingent fee basis.

Class Action Firm Recognition: Monteverde & Associates PC, a top class action firm based in New York, is investigating several proposed mergers involving companies like Servotronics, Southern States Bancshares, LENSAR, and iCAD, with specific shareholder actions and deadlines outlined for each case.

Legal Services Offered: The firm emphasizes its successful track record in recovering funds for shareholders and invites individuals with concerns regarding the listed companies to seek free information or legal assistance.

Investigation of Companies: Halper Sadeh LLC is investigating Inozyme Pharma, Servotronics, and Heliogen for potential violations of federal securities laws and breaches of fiduciary duties related to their sales to other companies at specified share prices.

Shareholder Rights: The law firm encourages shareholders from these companies to contact them for information on their legal rights and options, emphasizing that they operate on a contingent fee basis with no upfront costs for clients.